BiPAP Machines Market

Market Definition

Global BiPAP Machines market size is valued at USD 2466.5 million in 2025 and projected to grow at a CAGR of 5.6% during the forecast period, reaching USD 3814.2 million by 2033.

North America holds 36.8% in 2025 with US leading the market share in 2026.

BiPAP machine is a non-invasive therapy for patients suffering from sleep apnea, chronic obstructive pulmonary disease (COPD), asthma, and others. BiPAP machine provides pressurized air through a mask to the patient's airways. The air pressure helps the throat muscles from collapsing and reducing obstructions. BiPAPs can also be helpful for cardiopulmonary disorders such as congestive heart failure.

Market Dynamics

Rising prevalence of COPD, asthma, sleep apnea and other respiratory diseases is a key driving factor of the market. According to the World Health Organization (WHO), globally, there are more than 251 million cases of COPD in 2018. Globally, 3.17 million died due to COPD in 2018. More than 90% of COPD deaths occur in low and middle-income countries. According to the World Health Organization (WHO), in 2019, more than 339 million people are living with asthma, with 80% of deaths occur in low and lower middle-income countries. According to the World Health Organization (WHO), in 2018, more than 936 million are affected by sleep apnoea globally. In 2018, more than 175 million people in Europe had sleep apnoea. BiPap help to improve breathing problem. BiPap are used for the following conditions such as chronic obstructive pulmonary disorder (COPD), obstructive sleep apnea, asthma, obesity hypoventilation syndrome, pneumonia, poor breathing after an operation, and others. However, the side effects of the BiPAP machines might hamper market growth. The most common side effects of BiPAP therapy are the dry nose, nasal congestion, rhinitis, general discomfort, claustrophobia and in some most serious cases worsening lung function or injury. Moreover, government initiatives and support for respiratory devices that aid breathing would provide lucrative opportunities for the market in the coming years.

Market Segmentation

The global BiPAP machines market is mainly classified based on type, application, and end user. Type is further segmented into Auto BiPAP and BiPAP ST. By application, the market is divided into Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, and Others. By end user, the market is further divided into Hospitals, Ambulatory Surgical Centers, and Home Care.

Based on application sleep apnea was dominating the global BiPAP machines market in 2019, owing to the rising number of patients using breathing aid for sleep apnea, research and development activities to develop BiPAP machines for sleep apnea, and commercialization of new BiPAP machines for sleep apnea. For instance, Medequip Healthcare Solutions, manufacturer and importer of healthcare products, has introduced Hypnus Oxymed CPAP and BiPAP devices for sleep apnea therapy. Hypnus Oxymed automatically adjusts supply pressure to provide natural breathing. Hypnus Oxymed monitors the patients breathing to ensure effective exhalation and inhalation using an algorithm.

Regional Analysis

Based on geography, the global BiPAP machines market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the global BiPAP machines market in 2019, due to the commercialization of new BiPAP machines and partnership between companies to distribute BiPAP machines at the global scale and rising incidents of sleep apnea in North American countries. For instance, According to the National Sleep Foundation, 50-70 million US adults have a sleep disorder and obstructive sleep apnea. In 2018, an estimate of 22 million Americans suffered from moderate to severe sleep apnea. According to the Public Health Agency of Canada, more than 5.4 million Canadian adults have obstructive sleep apnea.

Competitive landscape

Key players operating in the BiPAP machines industry include ResMed, Philips, DeVilbiss Healthcare, Lowenstein Medical, 3B Medical, Hunan Beyond Medical, Respro India, and Nanotronics Imaging.

The increasing regulatory approval for BiPAP machines, the partnership between companies to develop and distribute BiPAP machines at the global scale, increasing studies on BiPAP machines by the companies, and commercialization of new BiPAP machines are some of the strategies adopted by the major companies. For instance, on June 11, 2020, Nanotronics has introduced nHale, a bi-level positive air pressure (BIPAP) device to support breathing adults weighing over 30 kg. The device has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) to assist patients suffering from COVID-19 disease. nHale is a noninvasive approach designed for patients in need of breathing assistance.

Report Attributes	Details
Study Period	2021-2033
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2033
Historical Period	2021-2025
Growth Rate	CAGR 5.6% from 2026 to 2033
Revenue Unit	USD million
Sales Volume Unit	Thousand Units
Segmentation	By Type, Application, Age Group, End User, and Region
By Region	North America (By Type, Application, Age Group, End User, and Country) United States Canada Mexico
	Europe (By Type, Application, Age Group, End User, and Country) Germany France UK Italy Spain Russia Rest of the Europe
	Asia Pacific (By Type, Application, Age Group, End User, and Country) China Japan India South Korea Australia Southeast Asia Rest of Asia Pacific
	South America (By Type, Application, Age Group, End User, and Country) Brazil Argentina Rest of South America
	Middle East and Africa (By Type, Application, Age Group, End User, and Country) Saudi Arabia UAE South Africa Rest of Middle East and Africa

BiPAP Machines Market Key Segments:

By Type:

• Auto BiPAP
• BiPAP ST

By Application:

• Chronic Obstructive Pulmonary Disease (COPD)
• Sleep Apnea
• Asthma
• Others

By Age Group:

• Adult
• Pediatric

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Home Care

Key Global BiPAP Machines Industry Players

• Air Liquide Medical Systems
• Beijing Aeonmed Co., Ltd.
• BMC Medical Co., Ltd.
• Breas Medical
• Dräger
• Drive DeVilbiss Healthcare
• GE HealthCare
• Hamilton Medical
• Hebei Topson Medical Technology Co., Ltd.
• Hunan Beyond Medical
• Koninklijke Philips N.V.
• Löwenstein Medical Technology GmbH
• Medtronic
• Nihon Kohden
• React Health
• ResMed Corp.
• Respro India
• SEFAM
• Sleep Works Medical Inc.
• Somnetics International, Inc.
• Yuwell